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Abstract
Newly activated CD8+ T cells reprogram their metabolism to meet the extraordinary biosynthetic 
demands of clonal expansion; however, the signals mediating metabolic reprogramming remain 
poorly defined. Herein, we demonstrate an essential role for sterol regulatory element binding 
proteins (SREBPs) in the acquisition of effector cell metabolism. Without SREBP signaling, 
CD8+ T cells are unable to blast, resulting in markedly attenuated clonal expansion during viral 
infection. Mechanistic studies indicate that SREBPs are essential to meet the heightened lipid 
requirements of membrane synthesis during blastogenesis. SREBPs are dispensable for 
homeostatic proliferation, indicating a context-specific requirement for SREBPs in effector 
responses. These studies provide insights into the molecular signals underlying metabolic 
reprogramming of CD8+ T cells during the transition from quiescence to activation.
Keywords
SREBP; LCMV; lipids; CD8+ T cell; metabolism; proliferation
A hallmark of adaptive immunity is the ability of responding T lymphocytes to undergo 
extensive clonal expansion to protect the host from invading pathogens. To fulfill the 
requirements of clonal expansion, activated T cells must acquire distinct metabolic programs 
that meet heightened metabolic demands. Quiescent, naive T cells rely on mitochondrial 
oxidative phosphorylation (OXPHOS) and catabolic metabolism to fulfill the minimal 
energetic and biosynthetic requirements associated with quiescence and long-term survival. 
Upon activation, T lymphocytes rapidly switch their metabolic program to rely 
predominantly on glycolysis in a process highly analogous to the Warburg effect first 
described for tumor cells 1. Additional changes in intermediary metabolism include 
increased flux through the pentose phosphate pathway (PPP) and an increased reliance on 
glutaminolysis. The preferential use of glycolysis, pentose-phosphate and glutaminolytic 
pathways enables rapidly dividing T cells to satisfy the increased metabolic demands during 
organelle biogenesis and cellular replication 2, 3. Accordingly, genetic and pharmacological 
inhibition of glycolytic, glutaminolytic and lipid biosynthetic pathways attenuate T cell 
survival, cell cycle progression and effector differentiation 4-9. Despite the importance of 
metabolic reprogramming for effector cell fate and function, the molecular events linking T 
cell receptor signaling with metabolic reprogramming remain enigmatic.
A key component in the metabolic reprogramming of effector T lymphocytes is the rapid 
upregulation of lipid biosynthetic pathways 4,8. Early isotopomer enrichment studies 
demonstrated that activation of lymphocytes results in the rapid increase of de novo 
cholesterol and fatty acid biosynthesis 4. Critically, addition of specific cholesterol 
derivatives (e.g., oxysterols) to cultures markedly diminished de novo lipid biosynthesis and 
inhibited cell cycle progression in G1, suggesting a link between lipid metabolism and cell 
cycle progression. Subsequent studies using statins, pharmacologic inhibitors of HMG-CoA 
reductase (the rate-limiting enzyme in de novo cholesterol biosynthesis) also inhibited 
mitogen-driven lymphocyte expansion 10. More recently, we and others have established 
that genetic and pharmacologic perturbations in sterol homeostasis, through the action of the 
Liver X Receptor (LXR) transcriptional axis, also influence T lymphocyte cell cycle 
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progression, survival and effector function 8, 11. Thus, the regulation of intracellular lipid 
metabolism is critical for proper lymphocyte growth and function. However, the molecular 
mechanisms linking mitogenic signaling to the lipid anabolic program of activated 
lymphocytes remain poorly defined.
The sterol regulatory element binding proteins (SREBP1 and 2) are bHLH-zip transcription 
factors that have a well-defined role in the regulation of cellular lipid homeostasis 12. In 
mammals there are two SREBP genes that express three SREBP proteins. SREBP1a and 
SREBP1c are produced via alternative transcriptional start sites on Srebf1, whereas the 
Srebf2 gene encodes SREBP2. Canonical SREBP1c signaling preferentially drives 
expression of fatty acid biosynthesis genes whereas SREBP2 predominately transactivates 
genes involved in cholesterol biosynthesis, intracellular lipid movement and lipoprotein 
import. The SREBP1a isoform is able to transactivate both SREBP1c and SREBP2 target 
genes. In addition to their function in regulating lipid biosynthetic and transport gene 
expression, SREBPs also transactivate key genes involved in the oxidative PPP and the 
generation of the co-enzyme NADPH 13, ensuring sufficient reducing equivalents to meet 
anabolic demands.
The influence of SREBP signaling on T cell metabolism and function is not well understood. 
Herein, we use genetic and pharmacologic models to demonstrate that SREBPs are essential 
for CD8+ T cells to undergo metabolic reprogramming in response to mitogenic signaling. 
Loss-of-SREBP function in CD8+ T cells rendered them unable to efficiently blast, resulting 
in diminished proliferative capacity in vitro, and attenuated clonal expansion during viral 
infection. SREBP activity was required for the upregulation of glycolytic and oxidative 
metabolism following activation and to maintain lipid levels sufficient to permit rapid 
membrane biogenesis and cellular growth. The defect in growth and proliferation was traced 
to a deficiency in cellular cholesterol during blastogenesis which could be rescued by 
cholesterol supplementation. However, SREBPs were dispensable for homeostatic 
proliferation, indicating a specific requirement for SREBP signaling to meet the significant 
anabolic demands supporting effector responses. This study provides mechanistic insights 
into the metabolic networks ensuring the growth of effector CD8+ T cells upon activation, 
and highlights the importance of SREBP proteins in regulating a cholesterol metabolic 
checkpoint during blastogenesis.
RESULTS
The TCR induces an mTOR-dependent lipid synthetic program
T cells rapidly upregulate a fatty acid and cholesterol lipid biosynthetic program after 
stimulation with polyclonal mitogens 4. To understand the relationship between mitogenic 
stimulation and induction of the lipogenic program, we activated purified murine T cells 
with plate bound anti-CD3 alone or in combination with anti-CD28 for 6 hours. Quantitative 
RT-PCR revealed that anti-CD3 alone was sufficient for induction of cholesterol (Hmgcr, 
Hmgcs, Sqle) and fatty acid biosynthesis genes (Acaca, Fasn) (Fig. 1a), and the addition of 
CD28 costimulation did not provide additional induction of the program. Activation of Pmel 
TCR transgenic CD8+ T cells with increasing doses of agonist gp100 peptide confirmed a 
requirement for TCR signaling and showed that induction of the lipogenic program occurs at 
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sub mitogenic doses of antigen (Supplementary Fig. 1a). T cell activation, using the phorbol 
ester PMA, induced the lipogenic program to levels comparable to that of TCR crosslinking 
(Fig. 1a). Induction was inhibited by pretreatment of cells with the PKC inhibitor Gö6983 
(Supplementary Fig. 1b), suggesting PKC dependence. In contrast, culturing cells with a 
calcium ionophore (ionomycin) alone did not induce lipogenic genes (Fig. 1a). Taken 
together, these data indicate that TCR signaling and PKC activation are necessary and 
sufficient for induction of the lipogenic program in mitogen-stimulated T cells.
Recent studies indicate that loss of Tsc1, a negative regulator of mTOR kinase signaling, 
resulted in the upregulation of sterol biosynthesis and propanoate metabolism genes in naive 
CD4+ T cells14. Thus, we asked if induction of lipid biosynthetic programs by mitogens was 
dependent on mTOR signaling. To address this, purified splenic T cells were pretreated for 
30 minutes with 100 nM rapamycin or vehicle and then stimulated up to 6 hours. As 
expected, activation of T cells robustly induced fatty acid and cholesterol biosynthetic 
genes, whereas 30 minutes pretreatment of cultures with rapamycin completely inhibited the 
induction of the lipogenic program (Fig. 1b). Immunoblots on whole cell and nuclear 
extracts revealed that rapamycin prevented processing of full length SREBP resulting in a 
failure to accumulate mature SREBP in the nucleus (Supplementary Fig. 1c). Inactivation of 
the PI3K pathway with LY294002 (Ly294) treatment similarly repressed lipogenic gene 
expression (Fig. 1b). These data indicate that signaling through the PI3K-mTOR pathway is 
necessary for the induction of the lipid anabolic gene program of activated lymphocytes.
SREBPs mediate the lipid anabolic program of T cells
To directly address the function of SREBPs in the induction of the lipogenic program by 
mitogenic signals, purified splenic and lymph node (LN) T cells were retrovirally transduced 
with a truncated form of SREBP1a or SREBP2 that is constitutively active (designated 
ΔSREBP1a or ΔSREBP2 herein, Supplementary Fig. 1d,e). mRNA was collected 24 h post 
infection and expression of the lipid biosynthetic genes were determined by RT-PCR. Both 
ΔSREBP1a and ΔSREBP2 markedly increased the expression of cholesterol and fatty acid 
biosynthesis genes when compared to empty vector controls (Fig. 1c), indicating that the 
lipogenic program of T cells is responsive to SREBP signaling.
In complementary experiments, we asked if SREBPs were required for induction of the 
lipogenic program by mitogenic signaling. To directly address this, purified mouse spleen 
and LN T cells were transiently transfected with siRNAs targeting SREBP1 and SREBP2 
before stimulation with PMA-ionomycin. After 5 h of stimulation, mRNA was collected and 
expression of lipid biosynthetic genes assessed. Activation of cells transfected with control 
siRNA increased expression of genes involved in de novo lipid biosynthesis (Fig. 1d). In 
contrast, siSREBP1 and siSREBP2 transfected cells were unable to upregulate cholesterol 
synthetic genes (Fig. 1d, Supplementary Fig. 1f). Upregulation of fatty acid biosynthetic 
genes was inhibited, albeit to a lesser extent. Knockdown of SREBP2 alone was sufficient to 
inhibit the induction of both cholesterol and fatty acid synthetic genes (Fig. 1d). We were 
only able to achieve a partial knockdown of SREBP1 (Supplementary Fig. 1f) and 
correspondingly, we observed a small, but statistically significant effect on fatty acid 
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synthetic genes (Fig. 1d). However, we were unable to inhibit sterol synthetic genes with 
this knockdown.
The observation that over-expression of ΔSREBP1a or ΔSREBP2 upregulates both fatty acid 
and cholesterol biosynthetic genes in activated T cells lead us to hypothesize that SREBP1 
and SREBP2 might cooperate, or share occupancy, at the promoters of lipogenic genes. 
Thus, we performed chromatin immunoprecipitations (ChIP) on SREBP1 and 2 from 
quiescent and activated T cell lysates. In quiescent cells, SREBP2 was readily detectable at 
the promoters of Hmgcr and Hmgcs (Fig. 1e). Activation of T cells resulted in a 10-fold or 
greater enrichment of SREBP2 at the promoters of Hmgcr and Hmgcs (Fig. 1e). Clear 
enrichment of SREBP1 was also detectable at the promoters of Hmgcr and Hmgcs, 
canonical SREBP2 target genes. Likewise, we could find both SREBP1 and 2 at the 
promoters of fatty acid synthetic genes (Fig. 1e). These data suggest that both SREBP1 and 
2 may cooperate in driving the lipogenic program of activated T cells. Pre-treatment of 
cultures with 25-hydroxycholesterol (25-HC, 10 μM), a well-described sterol inhibitor of 
SREBP processing markedly reduced enrichment of SREBP1 and 2 at the promoters of 
lipogenic genes (Fig. 1e), and consequently induction of the lipid synthetic program 
(Supplementary Fig. 1g). Lastly, pretreating cultures with 100 nM rapamycin also reduced 
SREBP1 and SREBP2 enrichment to background (Fig. 1e); further indicating that mTOR is 
required to link TCR signaling with induction of the lipid synthetic program via SREBP.
Deletion of the SCAP inhibits SREBP activity in T cells
Previous studies on SREBP proteins indicate that SREBP1 and 2 can compensate for each 
other when one protein is deleted 15, 16. Moreover, our overexpression and ChIP studies 
suggested that both SREBP1 and SREBP2 could potentially influence the lipid biosynthetic 
program in mitogen-stimulated T cells. Thus, we reasoned that loss of both SREBP1 and 
SREBP2 would be required to fully ablate the lipogenic program of activated T cells. To 
achieve this, we crossed mice containing floxed alleles of the SREBP chaperone protein 
SCAP (SREBP Cleavage Activating Protein) with Cd4-Cre mice (hereafter referred to as 
Scapfl/fl). SCAP protein is associated with SREBPs in the ER membrane and regulates the 
processing and subsequent transcriptional activity of both SREBP1 and SREBP2 17. 
Examination of 5-6 week-old Scapfl/fl and littermate control mice revealed no significant 
differences in the cellularity of thymus, spleen and LN (Fig. 2a). Phenotypic analysis of 
thymic and peripheral T cell subsets from Scapfl/fl and control mice demonstrated no 
demonstrable differences in the frequency of CD4+ and CD8+ T cells (Fig. 2b). Nor were 
there differences in the expression pattern of the activation markers (e.g., CD25 and CD44, 
Supplementary Fig. 2a), or total numbers of CD4+CD25+ and CD8+CD44+ cells observed 
(Supplementary Fig. 2b). Finally, BrdU pulse chase experiments to follow homeostatic 
maintenance of peripheral T cells revealed no significant difference in the labeling or decay 
between control and Scapfl/fl mice over a 42 day period (Supplementary Fig. 2c).
Gene expression studies confirmed a near complete deletion of Scap in quiescent peripheral 
Scapfl/fl T cells, and we observed a modest change in the expression of lipogenic genes (Fig. 
2c). ChIP studies demonstrated that T cell specific deletion of Scap modestly reduced the 
amount of detectable SREBP protein at target gene promoters in quiescent cells (Fig. 2d). 
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As expected, control cells rapidly upregulated the lipid biosynthetic program (Fig. 2c) and 
led to increased SREBP1 and SREBP2 at target gene promoters (Fig. 2d). In contrast, the 
induction of lipogenic genes was markedly attenuated in Scap-deficient CD8+ T cells (Fig. 
2c). Correspondingly, we observed a significant reduction in the amount of both SREBP1 
and SREBP2 protein occupying promoters of lipid biosynthesis genes (Fig. 2d). Taken 
together, our data indicate that the SREBP-dependent lipid biosynthetic program is largely 
dispensable for quiescent peripheral T cells; however, genetic deletion of Scap attenuates the 
upregulation of the SREBP transcriptome of mitogen-stimulated T cells.
SREBPs influence CD8+ T cell growth and proliferation
To determine if loss of SREBP activity would influence T cell blastogenesis and 
proliferation in vitro, purified control and Scapfl/fl CD8+ T cells were stimulated with anti-
CD3 with or without anti-CD28 or IL-2 for 72 h. Control T cells enlarged by 24 h (Fig. 3a 
and Supplementary Fig. 3a) and diluted CFSE by 72 h after activation (Fig. 3b). In contrast, 
Scapfl/fl CD8+ T cells did not undergo significant enlargement (Fig. 3a and Supplementary 
Fig. 3a), and only modestly proliferated in response to anti-CD3 (Fig. 3b). The addition of 
exogenous IL-2 and/or anti-CD28, or PMA-ionomycin to cultures provided only a slight or 
no increase in the proliferation of Scapfl/fl T cells (Fig. 3b). Cell cycle analysis indicated that 
activated Scapfl/fl CD8+ T cells remained in G0-G1 of cell cycle (Fig. 3c). The addition of 
CD28 and/or IL-2 to cultures very modestly increased the proportion of cells in S or G2-M 
phase (Fig. 3c). These data clearly indicate that SREBP signaling is essential for mitogen-
driven CD8+ T cell blastogenesis, proliferation and survival.
Our cell cycle data indicates that Scap deficient T cells remain in G0-G1 phase. To better 
define whether Scap-deficient T cells were capable of moving out of G0 into G1 of cell 
cycle, we examined the expression of the G1 associated cyclins and restriction point 
proteins. Immunoblots from control and Scapfl/fl CD8+ T cells activated for 18h indicated 
Scap-deficient T cells upregulated cyclins D2 and D3 (Fig. 3d). We also observed decreased 
phosphorylation of the cell cycle checkpoint protein Rb and maintenance of p27kip (Fig. 3d), 
suggesting that Scap-deficient cells were moving into G1 of cell cycle, but were not entering 
S phase. We also examined if the loss of SREBP activity was resulting in apoptosis. 
However, kinetic studies indicated no difference in the frequency of cleaved caspase-3-
positive cells up to 36 h post-activation (Fig. 3e). Similarly, we observed no difference in 
the frequency of annexin V-positive Scapfl/fl CD8+ T cells (data not shown). However, we 
did observe a significant decrease in the frequency of DAPI-negative cells by 48 h 
(Supplementary Fig. 3b), suggesting that loss of SREBP activity results in non-apoptotic 
death late in cultures. Taken together these data indicate that Scap-deficient T cells move 
efficiently into G1 of cell cycle, but are unable to exit before undergoing a caspase-
independent cell death.
Loss of SREBP impacts lipid homeostasis of T cells
Next, we asked if genetic ablation of SREBP activity grossly perturbed lipid homeostasis in 
T cells. To address this, splenic T cells were purified from 5-8 week old Cd4-Cre × Scapfl/fl 
or littermate control mice. Total cholesterol and fatty acid (myristate, palmitate and stearate) 
content were measured by Gas chromatography-Mass spectroscopy (GC-MS) directly ex 
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vivo. Scapfl/fl T cells contained an approximate 2-fold decrease in cellular cholesterol 
compared to littermate control T cells (Fig. 4a). Palmitate was also modestly decreased in 
quiescent Scap-deficient T cells (Fig. 4b), however no significant difference in myristate or 
stearate was observed in resting cells. Activation of control T cells with anti-CD3-28 for 24 
h increased cholesterol, myristate, palmitate and stearate (Fig. 4a,b). In contrast, Scapfl/fl T 
cells were unable to increase their cholesterol, myristate, palmitate and stearate content in 
response to activation (Fig. 4a,b). Taken together, these data indicate that SREBP signaling 
is required for defining a lipid homeostatic set point in quiescent T cells, and plays an 
essential role in meeting the increased lipid biosynthetic demands during blastogenesis.
Loss of SREBP does not perturb proximal TCR signals
Given the importance of cholesterol in plasma membrane fluidity18, lipid raft formation and 
TCR signaling 19, we considered the possibility that the diminished proliferative capacity 
and survival of Scapfl/fl CD8+ T cells was a function of altered proximal signaling. To 
address this, T cells were stimulated with anti-CD3 for 60 min and whole cell lysates were 
probed for phosphorylation of the upstream signaling molecules Zap-70, Lck, Lat and 
p44/42 MAPK. Regardless of genotype, we observed normal induction of phosphorylation 
as early as 5 minutes after stimulation, which was maintained out to 60 min (Fig. 4c). We 
also considered the possibility that we would observe alterations in the PI3K-AKT pathway 
given the importance of lipids (e.g., myristate) in proper activation of this pathway. 
However, we did not observe any difference in phosphorylation of AKT and the 
downstream target S6 in response to activation (Fig. 4d). Moreover, activation with PMA 
and ionomycin, which obviate the requirement for TCR and co-stimulation, did not provide 
a significant rescue in the cell cycle progression, viability and proliferative capacity of Scap-
deficient T cells (Fig. 3b,c). These data suggest that it is unlikely that the inability of Scap-
deficient T cells to grow is a function of changes in TCR and co-receptor signaling.
SREBPs regulate a gene program required for T cell growth
To better understand how SREBP was influencing CD8+ T cell growth and survival, we 
performed global gene expression studies on quiescent and 6 h stimulated CD8+ T cells. A 
number of genes were either up or downregulated with anti-CD3-CD28 stimulation in 
control CD8+ T cells. Importantly, we observed a very similar pattern of gene expression in 
activated Scap-deficient cells indicating that loss of SREBP activity does not globally 
perturb T cell activation. Pathway analysis of genes differentially expressed between 
quiescent control and Scap-deficient CD8+ T cells revealed a small set of genes involved in 
cellular survival was downregulated in the absence of SREBP activity (Supplementary Table 
1).
Analysis on genes significantly (P<0.001) less-induced in Scap-deficient CD8+ T cells after 
activation using DAVID software analysis20, 21 revealed significant enrichment in processes 
associated with sterol biosynthesis, confirming the effect of Scap-deficiency in reducing 
lipid anabolism in the context of T-cell activation (Fig. 5, Table 1, and Supplementary Table 
1). Other gene ontology clusters significantly enriched were associated with RNA 
homeostasis (e.g., RNA processing, ribosome biogenesis and rRNA metabolic processes), 
nuclear and organelle lumen and nucleolus biogenesis (Table 1). Analysis of predicted 
Kidani et al. Page 7
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
transcription factors mediating differential gene expression between activated control and 
Scapfl/fl CD8+ T lymphocytes revealed significant enrichment in SREBP1 and SREBP2, 
further validating that loss of SCAP protein influences SREBP-mediated lipid anabolism 
following T cell activation (Table 2). Loss of the transcriptional regulators CREBBP, NFY, 
and YY1 was also predicted, and since these have well-positioned roles in lipid metabolism, 
this likely reflect loss of the lipid anabolic program in Scap-deficient T cells. Taken 
together, these data indicate that SREBP signaling specifically regulates a gene program 
necessary for lipid anabolism and growth of T cells, but does not grossly influence T cell 
activation.
SREBP is required for metabolic reprogramming
To further interrogate the metabolic state of Scap-deficient T cells, we performed cellular 
bioenergetics analysis on quiescent and mitogen stimulated T cells. No difference in the 
basal extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) was 
observed between quiescent control and Scapfl/fl CD8+ T cells (Fig. 6a). Stimulation of 
control CD8+ T cells with anti-CD3-28 for 24 h resulted in a 10-fold increase in ECAR and 
a 4-fold increase in OCR. In contrast, Scapfl/fl CD8+ T cells only modestly increased OCR 
and ECAR, but were unable achieve the levels of control cells (Fig. 6a).
Next, we directly assessed mitochondrial function in Scap-deficient CD8+ T cells (ATP 
production and spare respiratory capacity) by monitoring the OCR in response to sequential 
treatment with oligomycin (ATPase inhibitor), FCCP (uncoupling agent) and the electron 
transport chain inhibitors rotenone and myxothiazol (Fig. 6b). Treatment of freshly isolated 
CD8+ T cells with oligomycin, FCCP and rotenone-myxothiazol revealed no difference in 
basal respiration, ATP production or spare respiratory capacity of quiescent control and 
Scapfl/fl CD8+ T cells (Fig. 6c). Activated control CD8+ T cells increased basal OCR, 
mitochondrial ATP production and spare respiratory capacity (Fig. 6c), consistent with 
significantly heightened mitochondrial function in blasting CD8+ T cells. In contrast, 
activated Scapfl/fl CD8+ T cells had significant deficiencies in basal respiration, ATP 
production and spare respiratory capacity (Fig. 6c), suggesting profound respiratory defects. 
We considered the possibility that the decrease in respiratory capacity was a function of 
perturbations in mitochondrial mass, however no difference in mitotracker staining was 
observed between control and Scap-deficient CD8+ T cells (Fig. 6d). Taken together, these 
data suggest that SREBP signaling is required for the acquisition of glycolytic metabolism 
and heightened mitochondrial respiration during CD8+ blastogenesis.
Glucose and glutamine are important carbon sources for energetics, anaplerosis 
(replenishment of TCA cycle intermediates) and macromolecular biosynthesis in activated 
lymphocytes7. Thus, we asked if SREBP signaling was influencing glucose and glutamine 
utilization in blasting T cells by directly measuring glucose, glutamine and lactate 
concentrations in culture media 24 hours after activation. Consistent with our ECAR data, 
we observed a marked decrease in lactate production by activated Scapfl/fl CD8+ T cells 
(Fig. 6e). We also observed a corresponding decrease in both glucose and glutamine 
consumption in activated Scapfl/fl CD8+ T cells (Fig. 6e). Kinetic analysis of [18F]-FDG (an 
18F-labeled glucose derivative) uptake by CD8+ T cells revealed that both control and Scap-
Kidani et al. Page 8
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
deficient CD8+ T cells initially increase their glucose uptake in response to activation (Fig. 
6f). However, Scap-deficient CD8+ T cells were unable to increase glucose uptake, resulting 
in an approximate 50% reduction in [18F]-FDG signals at 18 hours after activation.
RT-PCR analysis revealed that Scapfl/fl CD8+ T cells have significantly lower expression of 
glycolysis genes (Supplementary Fig. 4a). Both Myc and HIF1α have important roles in the 
upregulation of glycolytic program 22, thus we considered the possibility that Scap-deficient 
T cells might have perturbations in these pathways. However, immunoblots indicated 
normal upregulation of Myc, and increased stabilization of HIF1α in activated Scap-
deficient CD8+ T cells (Supplementary Fig. 4b). Thus, the inability of Scapfl/fl CD8+ T cells 
to acquire a glycolytic program during activation is likely not a direct function of altered 
Myc or HIF1α signaling.
A logical prediction of our metabolic studies is that blasting Scap-deficient T cells would 
have altered bioenergetics. To directly address this, we determined intracellular ATP 
concentrations in quiescent and anti-CD3-28 activated CD8+ T cells. No difference in ATP 
concentration was observed between control and Scapfl/fl CD8+ T cells directly ex vivo (Fig. 
6g). Activation of control CD8+ T cells modestly increased ATP levels by 6 h, and resulted 
in a 4-fold increase in cellular ATP by 24 h (Fig. 6g). In contrast, Scapfl/fl CD8+ T cells did 
not increase their cellular ATP concentration at 6h and increased ATP by 2-fold at 24 h post 
stimulation (Fig. 6g). We considered the possibility that perturbations in ATP levels would 
activate the AMP-activated protein kinase (AMPK) pathway in Scap-deficient CD8+ T cells. 
Consistent with earlier studies23, activation of control T cells resulted in phosphorylation of 
AMPK and the AMPK target acetyl-CoA carboxylase (ACC). No difference in p-AMPK 
and p-ACC from Scapfl/fl T cells was noted (Supplementary Fig. 4c), suggesting that the 
difference in glycolysis and cellular growth are not a function of exaggerated AMPK 
signaling. Taken together, these data support the notion that SREBP signaling influences 
cellular bioenergetics during blastogenesis independent of the Myc, HIF1α and AMPK 
pathways.
Cholesterol restores growth of Scap-deficient T cell
Our gene expression data indicates that loss of Scap primarily influences lipid homeostasis, 
in particular flux through the mevalonate pathway. In addition to cholesterol synthesis, the 
mevalonate pathway is responsible for the generation of non-steroidal lipid modification to 
proteins, such as prenylation (e.g., Ras) 8, 24. Thus, we asked if addition of excess mevalonic 
acid to cultures would increase flux into isoprenoid synthesis, and rescue cellular growth to 
Scap-deficient T cells. However, the addition of mevalonic acid (50-100μM) did not impact 
survival or blastogenesis (Supplementary Fig. 5a), suggesting that a defect in the prenylation 
of proteins could not mechanistically explain the phenotype of Scapfl/fl CD8+ T cells.
These data led us instead to posit that cholesterol was limiting in Scapfl/fl CD8+ T cells. To 
directly test this predication, control and Scap-deficient T cells were activated in complete 
media supplemented with 5μg/ml of cholesterol conjugated to Methyl-β-cyclodextrin 
(MBCD-Chol). Analysis of cultures up to 48 h revealed that addition of cholesterol to 
control CD8+ cells provided a modest increase in cellular survival, with no influence on size 
(Fig. 7a, Supplementary Fig. 5b). In contrast, Scap-deficient T cells doubled their survival at 
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48 h from 21 % to 45%, approaching that of control T cells without supplemental 
cholesterol (54%). Furthermore, supplementation with cholesterol restored the cellular 
enlargement of Scapfl/fl CD8+ T cells following activation with anti-CD3-28 (Fig. 7a,b). 
Analysis of cell cycle 48 h after stimulation indicated that addition of cholesterol markedly 
increased the frequency of Scapfl/fl CD8+ T cells in S and G2-M (Fig. 7c). Likewise, CFSE 
analysis indicated that Scap-deficient T cells were now able to undergo robust proliferation 
in response to mitogenic stimulation (Fig. 7d).
Cellular cholesterol levels have been implicated in regulating phospholipid synthesis. The 
observation that replenishing cholesterol was sufficient to significantly restore the growth of 
Scap-deficient T cells led us to ask if membrane biogenesis was diminished in the absence 
of SREBP activity. Membrane biosynthesis occurs in the endoplasmic reticulum (ER) before 
shuttling to other intracellular organelles or the plasma membrane. Thus, we assessed total 
ER content by flow cytometry in quiescent and newly activated cells using ER tracker. 
Quiescent Scapfl/fl CD8+ T cells had decreased ER content when compared to their control 
counterparts (Fig. 7e). Activation of control cells led to the addition of ER (Fig. 7e). In 
contrast, Scapfl/fl CD8+ T cells were unable to expand the ER during blastogenesis (Fig. 7e). 
However, the addition of exogenous cholesterol restored ER growth (Fig. 7f). These data are 
consistent with previous work implicating SREBPs in membrane biogenesis 25, and support 
the notion that intracellular cholesterol serves as a metabolic checkpoint in cell cycle 
progression via regulation of ER membrane biogenesis.
SREBPs intrinsically regulate virus-specific immunity
To determine if SREBP signaling was also required for efficient T cell clonal expansion in 
vivo, Scapfl/fl and control mice were challenged with LCMV Armstrong (Arm). LCMV-Arm 
infection of wild type mice generates a robust virus-specific T cell response leading to rapid 
control of virus infection within 10-12 days 26. On day 8 following infection, splenocytes 
were counted and stained with LCMV-specific DbGP33 tetramers to determine the level of 
virus-specific CD8+ T cell. Scapfl/fl mice exhibited a significant decrease in the frequency 
and total number of DbGP33-specific CD8+ T cells (Fig. 8a-c). A similar decrease was 
observed in the DbNP396-specific CD8+ T cell, indicating a globally diminished antiviral T 
cell response (Fig. 8c). Intracellular interferon-γ (IFN-γ) and tumor necrosis factor (TNF) 
staining in response to GP33 peptide challenge ex vivo confirmed a decrease in the 
frequency of responding CD8+ T cells (Fig. 8d,e). The few LCMV-specific CD8+ T cells 
that were generated in Scap-deficient mice, displayed decreased expression of IFN-γ and 
TNF (Fig. 8d), suggesting a potential functional defect in the absence of SREBP activity.
Finally, our data indicates an essential requirement for SREBPs in mitogen-driven 
proliferation in vitro and clonal expansion of viral-specific CD8+ effector cells in vivo. 
However, we did not observe significant perturbations in the frequency or absolute numbers 
of peripheral T cells from naive Cd4-Cre-Scapfl/fl mice (Fig. 2). These data led us to posit 
that SREBP activity might not be required under homeostatic conditions. To initially address 
this, we examined the homeostatic proliferation of purified, CFSE-labeled CD8+ T cells 
adoptively transferred in to Thy1.1+RAG2-deficeint hosts. On day 6 following adoptive 
transfer, CFSE dilution of Thy1.2+ T cells from LN and spleen was assessed. Consistent 
Kidani et al. Page 10
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
with our hypothesis, we observed no difference in the proliferative patterns of Scap-deficient 
and control T cells (Fig. 8f). Similar proliferative results were seen in a sub-lethal irradiation 
model of homeostatic proliferation 27 (Fig. 8f). RT-PCR revealed that homeostatically 
proliferating cells did not upregulate the SREBP driven cholesterol synthetic genes (Fig. 
8g), although we did observe a very modest upregulation of Fasn. Thus we posited that a 
major difference between T cells undergoing homeostatic proliferation versus conventional 
antigen-driven proliferation might be cellular growth. Indeed, analysis of cell size indicated 
that homeostatically proliferating OT-I cells remained small despite undergoing significant 
proliferation whereas OVA immunized OT-I cells underwent conventional blastogenesis 
(Fig. 8h). Taken together, these data reveal a context specific requirement for SREBP 
signaling during conventional antigen-driven responses to support cellular enlargement and 
effector function.
DISCUSSION
The molecular events guiding the metabolic reprogramming of T cells during activation 
remain poorly understood. Our studies convincingly demonstrate that SREBPs are essential 
to coordinate TCR signaling with a lipid anabolic program requisite for rapid membrane 
biosynthesis and cellular growth. In the absence of SREBP signaling, newly activated CD8+ 
T cells move into G1 of the cell cycle but are unable to grow, resulting in decreased 
proliferative capacity and markedly attenuated anti-viral immune responses. Strikingly, this 
defect in growth and proliferation was traced to an insufficiency in cholesterol. These data 
support a model where an intracellular cholesterol pool, likely in the endoplasmic reticulum 
– the site of lipid biosynthesis – serves as a metabolic signal conveying the fitness of a 
blasting T cells. Consequently, the SREBP gene program facilitates the transition of 
mitogen-stimulated T cells through a critical metabolic checkpoint during blastogenesis. 
These signals ensure coordination of cellular metabolism with cell cycle. Simply put, 
without sufficient cholesterol, effector T cells are unable to grow in response to 
conventional antigen stimulation.
One quite surprising aspect of our study is that SREBP activity is dispensable for 
homeostatic proliferation of CD8+ T cells. SREBPs have importance in regulating the 
proliferative capacity and survival of cancer cells 28, 29, albeit through poorly described and 
disparate mechanisms. The influence of SREBPs on primary cell proliferation is even less 
well understood. Our studies on conventional antigen-driven proliferation and anti-viral 
immunity clearly support the concept that SREBPs influence rapid cellular growth. 
Nevertheless, the observation that Scap-deficient T cells have no observable defects in 
homeostatic proliferation is the first clear evidence that there are differential requirements 
for SREBP signaling during proliferation. As such, the emerging notion that engagement of 
the SREBP pathway is universally required for cellular proliferation and survival is likely 
incorrect. Alternatively, we would propose that SREBP signaling is necessary under 
circumstances where cells require the rapid addition of biomass, rather than proliferation per 
se.
An interrelated and important concept centers on the observations that effector and memory 
CD8+ T cells employ distinct metabolic programs. Generation of effector CD8+ T cells 
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appears to be favored by glycolytic and anabolic programs, whereas memory T cell 
generation is enhanced under heightened OXPHOS and catabolism 2, 30. Our metabolic 
studies indicate that SREBP signaling is required for a CD8+ T cell to fully acquire a 
glycolytic phenotype. One intriguing possibility is that inhibition of SREBP in responding T 
cells could preferentially enrich for memory at the expense of effector cell generation. 
Recent studies have indicated that moderate inhibition of mTOR signaling with low dose 
rapamycin favors the generation of memory CD8+ T cells 31, 32. Other studies indicate that 
mTOR signaling controls cellular metabolism through the HIF and SREBP transcription 
factors 33, and the data presented here clearly indicate that SREBP in CD8+ T cells is 
rapamycin-sensitive during T cell activation. A logical prediction of these studies is that low 
dose rapamycin is favoring the development of CD8+ memory cells through its effects on 
SREBP activity. Future studies will be required to rigorously test this prediction. 
Nevertheless, our data raise the possibility that generation of memory and effector cells 
could be uncoupled via manipulation of sterol metabolism.
In conclusion, these studies delineate a role for SREBP in controlling conventional antigen-
driven clonal expansion, but not homeostatic proliferation. These observations could have 
significant implications for developing novel therapeutic strategies targeting this pathway to 
control unwanted effector T cell proliferation, without perturbing homeostasis or 
development.
Methods
Mice
Scapflox/flox 17 and C57/BL6 mice were purchased from the Jackson Laboratory. Cd4-Cre 
mice were purchased from Taconic. Scapflox/flox mice were crossed with Cd4-Cre mice to 
generate Cd4-Cre/Scapflox/flox mice. Cd4-Cre/Scap+/+ mice were used as littermate control 
for all experiments using Cd4-Cre/Scapflox/flox mice. All mice were maintained in pathogen 
free facilities of the University of California, Los Angeles. All experiments on mice and 
tissues collected from mice were performed in strict accordance with University of 
California, Los Angeles policy on the humane and ethical treatment of animals.
Cell culture and reagents
Cells were cultured in IMDM supplemented with 10% heat inactivated FBS, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 50 uM 2-ME. Total T cells or CD8+ T cells were 
purified using negative enrichment kit (STEMCELL Technologies). T cells were cultured in 
96-well plates coated with 5 μg/ml of anti-CD3 (2C11;Bio X Cell) alone or in combination 
with 2 μg/ml of soluble anti-CD28 (37.51;Bio X Cell) or 100 IU/ml of human IL-2. 
Alternatively, cells were cultured with 50 ng/ml of PMA (EMD Chemicals) alone or in 
combination with 500 ng/ml of ionomycin (Sigma-Aldrich). For proximal TCR signaling 
analysis, splenocytes were cultured with 1 μg/ml of soluble anti-CD3. In some experiments, 
cells were cultured with following inhibitors for 30 min prior to activation: Gö6983 (Sigma-
Aldrich), Ly294002 (EMD Chemicals), Rapamycin (EMD Chemicals), 25-
hydroxycholesterol (Sigma-Aldrich).
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Virus transduction
Truncated forms of SREBP1a or SREBP2 (Supplementary Fig. 1c) were cloned into the 
retrovirus vector MIGR1 (a gift from Dr. Yukiko Tone and Dr. Masahide Tone, Cedars-
Sinai, Los Angeles, USA). Virions were produced using the 293T cell line by transfection 
using Lipofectamine 2000 (Invitrogen). Purified naiveT cells were stimulated in 6-well 
plates pre-coated with 5 μg/ml of anti-CD3 supplemented with 2 μg/ml of anti-CD28 at 2 × 
106 cells/well. At 24 hours, cells were transduced by centrifugation in viral medium plus 8 
μg/ml of polybrene and 100 IU/ml of IL-2 at 1200 rpm for 90 min at 37 °C. Medium was 
then replaced with complete IMDM supplemented with 100 IU/ml of IL-2 and cells were 
incubated for additional 24 hours. Control cells were subjected to the same stimulation and 
centrifugation as transduced cells but without virus. After a total of 48 hours of stimulation, 
cells were harvested and transduction efficiencies were evaluated by GFP expression level 
on flow cytometry.
RNA interference
Purified T cells were transfected with non-target siRNA, SREBP1 siRNA, or SREBP2 
siRNA (Dharmacon) using Nucleofector according to manufacture’s protocol (Lonza). 
Transfected cells were rested for 18 hours at 37 °C and then stimulated with PMA and 
ionomycin for 5 hours.
Quantitative real-time PCR analysis
RNA was isolated using Trizol (Invitrogen). cDNA was synthesized using iScript cDNA 
Synthesis Kit (BIO-RAD). qRT-PCR was performed using SYBR Green I Master (Roche) 
on LightCycler 480 (Roche). Primer sequences are available upon request.
Flow cytometry analysis
7-ADD, anti-mouse CD4 (RM4-5), CD8 (53-6.7), CD25 (PC61.5), CD44 (IM7), Thy1.2 
(53-2.1), IL-7R (CD127), KLRG1 (2F1), INFγ (XMG1.2), TNFα (MP6-XT22), and IL-2 
(JES6-5H4) were purchased from eBioscience, BioLegend, or BD Biosciences. Active 
caspase3 and annexin V staining kits were purchased from BD Bioscience. CFDA SE, ER-
Tracker Blue-White DPX, and DAPI were purchased from molecular probe. Propidium 
Iodide was purchased from Calbiochem. Cells were analyzed on LSRII or FACSVersa with 
FlowJo software (Treestar).
Immunoblot analysis
Whole cell extracts were produced from equivalent number of cells with RIPA buffer 
(50mM Tris-HCl [pH 8.0], 150mM NaCl, 1% NP40, 0.5% Deoxycholate, 0.1% SDS) 
supplemented with Calyculin A (Cell Signaling) and protease inhibitor cocktail (Sigma-
Aldrich). Samples were separated on a 4-12% Bis-Tris gel and transferred to nitrocellulose. 
Antibodies for phospho-Akt (S473), Akt1 (5C10), Actin (I-19) were purchased from Santa 
Cruz Biotechnology. Antibody for HIF1α was from Cayman Chemical. Antibodies for S6 
ribosomal protein (54D2), phospho-S6 (S235/236)(D57.2.2E), Rb (D20), phospho-Rb 
(Ser807/811), p27Kip1, Cyclin D2 (D52F9), Cyclin D3 (DCS22), MYC, phospho-Zap70 
(Tyr319)/Syk (Tyr352)(65E4), phospho-Lck (Tyr505), LAT, phospho-LAT (Tyr191), 
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p44/42 MAPK (137F5), phospho-p44/42 MAPK (Thr202/Tyr204)(D13.14.4E), AMPK 
(F6), phospho-AMPK (Thr172)(40H9), phospho-ACC (Ser79) were from Cell Signaling.
Chromatin immunoprecipitation analysis
The method is described elsewhere34. Briefly, 2×107 cells were fixed and sonicated. 
Precleared lysates were incubated overnight at 4 °C with polyclonal anti-SREBP1 and anti-
SREBP2, or control rabbit IgG (Cell Signaling). Immunocomplex was collected and real-
time PCR was performed as described above. Primer sequences are available upon request.
Gene expression analysis
RNA isolated from littermate control and Scap-deficient CD8+ T cells and hybridized to 
Affymetrix GeneChip Mouse Genome 430 2.0 Array. Genes were filtered for differential 
expression across the samples by requiring an ANOVA p-value less than 0.001. For heatmap 
display, genes were mean centered, normalized and clustered using a Pearson correlation 
coefficient metric and pairwise complete-linkage. Pathway enrichment analysis was done 
with DAVID 20, 21. Transcription factor analysis was generated through the use of IPA 
(Ingenuity Systems, www.ingenuity.com).
Metabolic assays
Cellular ATP levels were measured from the same number of live cells using ATP 
determination kit according to the manufacture’s protocol (Molecular Probes). Background 
was measured using buffer without cells and subtracted from the values of each cell sample. 
For mitochondrial mass, cells were incubated with 50 nM MitoTracker green (Molecular 
Probes) at 37 °C for 30 min. The oxygen consumption rate and extracellular acidification 
rate were measured with a XF24 analyzer according to the manufacture’s 
recommendations 35. Mixing, waiting and measure times were 2, 2, 4 minutes, respectively. 
Test compounds were obtained from Sigma and injected during the assay at the following 
final concentration: 0.2 μM oligomycin, 1 μM FCCP, 0.75 μM Rotenone/Myxothiazol. 
Glucose, glutamine, and lactate concentrations in culture media were measured using 
bioprofile analyzer (Nova Biomedical).
Cholesterol loading
Cholesterol:MβCD complex containing 40 mg of cholesterol/g was purchased from Sigma 
(C4951). Treatment concentration was based on cholesterol weight. Cells were activated 
with or without cholesterol:MβCD in 10% FBS for indicated time.
GC-MS
Purified T cells were collected at ex vivo or after 24 hours of activation with plate-bound 
anti-CD3 in combination with soluble CD28 and washed twice with PBS. Fatty acids 
extractions and analyses were performed as previously described 36 with the modifications 
described below. Triheptadecanoin (Nu-chek Prep, T-155) was used as the internal standard 
for fatty acids. Ergosterol (Sigma 17130-U) was used as the internal standard for cholesterol. 
Internal standards were added to trizol. Cholesterol was extracted from organic phase with 
petroleum ether after saponification but before acidification and fatty acid extraction. 
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Extracted cholesterol was trimethylsilylated with BSTFA and TMCS (Sigma 33155-U). 
Extracted fatty acids were derivatized into their methyl ester form with methanolic boron 
trifluoride. Derivatized cholesterol and ergosterol were monitored at m/z 456-467 and 468 
respectively. Derivatized myristate, palmatate, heptadecanoate, and sterate were monitored 
at m/z 241-250, 269-278, 284, and 297-306 respectively. Data was collected on an Agilent 
5975C MSD connected to an Agilent 7890 Gas Chromatograph with the Phenomenex ZB-
MR-1 column. Settings and oven programs are available upon request. Area under the curve 
quantitation for selected ions was performed on Chemstation software.
LCMV infection, MHC I tetramer and intracellular cytokine staining
Mice were infected intraperitoneally (i.p.) with 2 × 104 plaque forming units (PFU) of 
LCMV-Armstrong. Virus stocks were prepared and viral titers were quantified as described 
previously 37. Splenocytes were stained directly ex vivo with LCMV-DbGP33-41 or LCMV-
DbGP396-404 specific tetramers and for surface expression of CD8. MHC tetramers were 
obtained from the NIH Tetramer Core Facility. To analyze cytokine expression, splenocytes 
were stimulated for 5 hours with 2 μg/ml of the MHC class I restricted LCMV-GP33-41 or 
NP396-404 peptide in the presence of 50 U/ml recombinant murine IL-2 (R&D Systems) and 
1mg/ml brefeldin A (Sigma-Aldrich). Cells were stained for surface expression of CD8, then 
fixed, permeabilized and stained with antibodies to TNF, IFN-γ and IL-2 (BioLegend). Flow 
cytometric analysis was performed using an LSR II or the FACSVerse (Becton Dickinson) 
and analyzed using FlowJo software (Treestar).
Adoptive cell transfer
CD8+ T cells or total T cells were purified from Scapfl/fl and control littermate mice or 
Thy1.1 mice spleens as above. Purified cells were labeled with CFSE and 1-5 × 106 cells/
mouse were injected via retro-orbital into RAG-deficient host or irradiated host 1 day earlier 
with 600 rad. After 6 days, host spleen and LN cells were analyzed by flow cytometry. For 
gene expression analysis, Thy1.1+ T cells were sorted and real-time PCR was performed as 
described above.
OVA peptide-IFA immunization
Forty-eight hours after the OT-I cell transfer, mice were either left unimmunized or 
immunized with total of 300 μg of OVA peptide mixed in IFA into 3 sites in upper back and 
3 sites in lower back (n=3 per group). Spleen and lymph nodes were harvested 24 hours later 
and CD3+CD8+ cells were analyzed on flow cytometry.
BrdU labeling
BrdU flow kit was purchased from BD Bioscience. BrdU (2 mg/mouse) was injected to 
Cd4-Cre/Scapflox/flox and littermate control mice intraperitoneally. Peripheral blood was 
collected twice a week and mononuclear cells were stained and analyzed on flow cytometry 
according to manufacture’s protocol.
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Statistical analysis
Statistical significance was determined with the two-tailed unpaired Student’s t-test unless 
otherwise indicated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The lipid biosynthetic program of activated T cells is SREBP-dependent and sensitive 
to the PI3K-mTOR pathway
(a) Real-time PCR analysis of lipogenic genes from murine spleen and LN T cells activated 
for 6 h with plate-bound CD3+/-CD28, PMA and ionomycin as indicated. (b) Real-time 
PCR analysis of quiescent or 6 h activated T cells pretreated for 30 min with PI3K inhibitor 
LY294002 (10 μM) or mTOR inhibitor rapamycin (100 nM) before activation with CD3-28. 
(c) Real-time PCR analysis of lipogenic genes in activated T cells transduced with active 
SREBP (ΔSREBP1a or ΔSREBP2) or empty vector (EV) for 24 h. * denotes comparisons 
between empty vector and ΔSREBP1a, † denotes comparisons between empty vector and 
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ΔSREBP2. Number of symbols indicates the p value. (d) Real-time PCR analysis of 
quiescent or T cells transfected with siSREBP1 alone, siSREBP2 alone, siSREBP1 and 
siSREBP2 or non-target control (siControl) and then activated with PMA-iono for 5 h. * 
denotes comparisons between siControl and siSREBP1, † denotes comparisons between 
siControl and siSREBP2, § denotes comparisons between siControl and siSREBP1+2. (e) 
Chromatin Immunoprecipitation analysis of SREBP1 and SREBP2 at the promoters of 
indicated genes in splenocytes ex vivo or 4 hours after activation with PMA. In addition, 
some cultures were pretreated for 30 minutes with rapamycin (100 nM) or 25-
hydroxycholesterol (25-HC, 10 μM) before activation. Data is normalized to input and 
expressed relative to IgG control. Rplp0: non-SREBP target gene control. * Denotes 
comparisons between vehicle and rapamycin treated samples, † denotes comparisons 
between vehicle and 25-HC treated samples. Inset: Immunoblot of phospho and total S6 
from whole cell lysates to confirm rapamycin function. For all experiments, data are 
presented as a mean of triplicates with standard deviation, and representative of at least three 
experiments. *p<0.05, **p<0.01, ***p<0.001 (statistical difference between other 
experimental groups is also noted by the number of other symbols, two-tailed unpaired 
Student’s t-test).
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Figure 2. Deletion of Scap inhibits SREBP activity but does not affect T cell homeostasis
(a) Total cell number in thymus, spleen and lymph nodes (LN) from Cd4-Cre-Scapfl/fl mice 
(designated Scapfl/fl herein) and littermate controls (WT). Data is expressed as mean with 
standard deviation. (b) Flow cytometric analysis of CD4+ and CD8+ T cells in thymus, 
spleen and LN from Scapfl/fl and littermate control mice. Relative frequency indicated in 
plots. (c) Real-time PCR analysis of control and Scapfl/fl CD8+ T cells ex vivo or activated 
for 6 h with anti-CD3-28. (d) Chromatin immunoprecipitation analysis of SREBP1 and 
SREBP2 at the promoters of indicated genes in T cells ex vivo or 6 hours after activation 
(anti-CD3-28). Data are normalized to input and plotted relative to IgG control. Rplp0: non-
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SREBP target gene control. * denotes comparisons between WT T=0 and Scapfl/fl T=0, † 
denotes comparisons between WT T=6 and Scapfl/fl T=6. Data are mean of triplicates with 
standard deviation (c,d). *p<0.05, **p<0.01, ***p<0.001 (statistical difference between 
other experimental groups is also noted by the number of other symbols, two-tailed unpaired 
Student’s t-test). Data are representative of four independent experiments with three mice 
per group (a,b), or three independent experiments (c,d).
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Figure 3. SREBP activity influences CD8+ T cell growth and proliferation
(a) Forward and side scatter plots of DAPI-negative (live) WT and Scapfl/fl CD8+ T cells 
activated with anti-CD3-28 for indicated time. (b) CFSE dilution of DAPI negative (live) 
WT and Scapfl/fl CD8+ T cells activated for 72 hours with indicated mitogens. (c) Flow 
cytometric analysis of DNA content from WT and Scapfl/fl CD8+ T cells activated for 48 
hours with indicated stimuli. Cells were stained for DNA content with propidium iodide. 
Frequency of S and G2/M phase indicated in plots. (d) Immunoblots of G1 associated cell 
cycle proteins from whole cell lysates of quiescent or 18 h activated WT and Scapfl/fl CD8+ 
T cells with anti-CD3-28. (e) Flow cytometric analysis of intracellular cleaved caspase-3 in 
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WT and Scapfl/fl CD8+ T cells activated with anti-CD3-28 for indicated time. Data are 
representative of three (a), or two (b,c,d,e) independent experiments.
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Figure 4. Loss of SREBP signaling impacts lipid homeostasis but does not perturb proximal 
TCR signaling
(a,b) GC-MS determination of cholesterol (a) or indicated long-chain fatty acid (b) content 
of control and Scapfl/fl T cells ex vivo or 24 h after activation with anti-CD3-28. Data are 
normalized to cell numbers and plotted relative to control ex vivo (WT 0 h). Data is 
expressed as mean of triplicates with standard deviations. (c) Immunoblot analysis of WT 
and Scapfl/fl lymphocytes ex vivo or after stimulation with 1 μg/ml of soluble anti-CD3e for 
the indicated time. Whole cell lysates were blotted for indicated total and phosphorylated 
proteins. (d) Immunoblot analysis of the Akt pathway from WT and Scapfl/fl CD8+ T cells 
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ex vivo or after 6 h of activation with anti-CD3-28. NS: not significant, *p<0.05, **p<0.01, 
***p<0.001 (two-tailed unpaired Student’s t-test).
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Figure 5. SREBP activity influences a transcriptional program related to lipid and RNA 
metabolism
Heat map of genes expressed in purified quiescent or 6 h stimulated (anti-CD3-28) WT and 
Scapfl/fl CD8+ T cells (all changes in gene expression met criteria of p<0.001 to be 
considered as significant). Less (act): less induced in activated Scapfl/fl CD8+ T cells. More 
(act): more induced in activated Scapfl/fl CD8+ T cells. Less (q): less induced in quiescent 
Scapfl/fl CD8+ T cells.
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Figure 6. SREBP signaling is required for metabolic reprograming of activated CD8+ T cells
(a) Basal oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of 
quiescent and 24 h stimulated WT and Scapfl/fl CD8+ T cells. (b) A schematic of OCR in 
basal condition and in response to sequential treatment with oligomycin (oligo: ATPase 
inhibitor), FCCP (uncoupling agent) and rotenone-myxothiazol (Rot-Myxo: electron 
transport chain inhibitor). Basal resp: basal respiration, ATP: ATP production, Max resp: 
maximal respiration, Non-mito resp: non-mitochondrial respiration, SRC: spare respiratory 
capacity (c) OCR of 24 h activated WT and Scapfl/fl CD8+ T cells in basal state and in 
response to sequential treatment with oligomycin, FCCP and rotenone-myxothiazol. (d) 
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Mitotracker staining of WT and Scapfl/fl CD8+ T cells ex vivo and after 24h of activation 
with anti-CD3-28. (e) Glucose and glutamine consumption, and lactate production 
measurement in spent media from activated WT and Scapfl/fl CD8+ T cell activated for 24 h 
with anti-CD3-28. (f) 2-deoxy-2-(18F)fluoro-D-glucose (FDG) uptake assay. CD8+ T cells 
were activated with anti-CD3-28 for indicated time. Cultures were pulsed with [18F]FDG for 
60 min before analysis. (g) Cellular ATP levels in quiescent, 6 or 24 h activated WT and 
Scapfl/fl CD8+ T cells (anti-CD3-28). Data are mean of triplicates with standard deviation 
and representative of two (c) or three (d) independent experiments. *p<0.05, **p<0.01, 
***p<0.001 (two-tailed unpaired Student’s t-test).
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Figure 7. Addition of cholesterol rescues growth and proliferation impairment of Scap-deficient 
CD8+ T cells
(a) Viability of WT and Scapfl/fl CD8+ T cell activated with anti-CD3-28 for 48 h with or 
without 5 μg/ml of MβCD conjugated cholesterol in 10% FBS supplemented media. DAPI-
negative (live) cell populations are gated and the frequencies are indicated in plots. (b) 
Forward and side scatter plots of DAPI-negative (live) WT and Scapfl/fl CD8+ T cell 
activated with anti-CD3-28 for 48 h with or without 5 μg/ml of MβCD-cholesterol in 10% 
FBS supplemented media. (c) Flow cytometric analysis of DNA content from WT and 
Scapfl/fl CD8+ T cells activated for 48 hours with or without 5 μg/ml of MβCD-cholesterol 
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in 10% FBS supplemented media. Cells were stained for DNA content with propidium 
iodide. Frequency of S and G2/M phase indicated in plots. (d) CFSE dilution of DAPI 
negative (live) WT and Scapfl/fl CD8+ T cells activated for 48 hours with or without 5 μg/ml 
of MβCD-cholesterol in 10% FBS supplemented media. (e) ER-tracker staining of WT and 
Scapfl/fl CD8+ T cells ex vivo or after activation with anti-CD3-28 for indicated time. (f) 
ER-tracker staining of WT and Scapfl/fl CD8+ T cells activated for 48 hours with or without 
5 μg/ml of MβCD-cholesterol in 10% FBS supplemented media.
Kidani et al. Page 31
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 8. Loss of SREBP activity impairs clonal expansion of antigen specific effector CD8+ T 
cells, but does not perturb homeostatic proliferation
(a) Absolute numbers of splenocytes and CD8+ T cells from spleen harvested on day 8 of 
LCMV Armstrong (Arm) infection. (b) Frequency of DbGP33-tetramer specific CD8+ T 
cells from spleen harvested on day 8 of LCMV-Arm infection. Frequency of cells marked in 
quadrants of FACS plots. (c) Absolute numbers of CD8+DbGP33-tetramer+ cells and 
CD8+NP396-tetramer+ cells from spleen harvested on day 8 of LCMV-Arm infection. (d,e) 
Frequency (d) and absolute number (e) of IFN-γ or TNF producing WT and Scapfl/fl CD8+ 
T cells harvested on day 8 of LCMV-Arm infection and stimulated with GP33-peptide for 
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5h in vitro. Frequency and mean fluorescent intensity (MFI) of cytokine producing CD8+ T 
cells indicated in right upper quadrant of FACS plots. (f) CFSE dilution gated on Thy1.2+ 
CD8+(top), and CD3+CD4+or CD3+CD8+ (bottom) cells on day 6 after adoptive transfer 
into RAG-deficient Thy1.1+ mice (top) or irradiated littermate WT mice (bottom). (g) Real-
time PCR analysis of Thy1.1+ T cells adoptively transferred into RAG-deficient Thy1.2+ 
mice and sorted from spleens and LNs after 6 days. (h) Forward scatter plots of OT-I cells. 
Cells were adoptively transferred into RAG-deficient mice and either left untreated (UT) or 
immunized (Im) with OVA/IFA subcutaneously. Twenty-four hours later, cells from spleens 
and LNs were stained as described in Methods and analyzed on flow cytometry. Pre: pre-
transfer. *p<0.05, **p<0.01 (two-tailed unpaired Student’s t-test).
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Table 1
Pathway enrichment analysis of genes less induced in 6 h activated Scapfl/fl versus WT 
CD8+ T cells using DAVID (NIAID)
The number of genes enriched in each pathway (designated “count”) and associated p values are indicated.
Enrichment cluster 1: Score 7.09 Count P Value
 sterol biosynthetic process 10 6.20 × 10-14
 sterol metabolic process 12 6.10 × 10-13
 steroid biosynthetic process 11 8.50 × 10-12
 cholesterol biosynthetic process 8 3.90 × 10-11
 steroid metabolic process 13 1.30 × 10-10
 cholesterol metabolic process 10 2.30 × 10-10
 lipid biosynthetic process 14 8.90 × 10-9
 isoprenoid biosynthetic process 4 2.70 × 10-4
 isoprenoid metabolic process 4 2.90 × 10-3
 oxidation reduction 11 5.40 × 10-3
Enrichment cluster 2: Score 4.33 Count P Value
 nuclear lumen 20 2.90 × 10-7
 intracellular organelle lumen 22 7.00 × 10-7
 organelle lumen 22 7.30 × 10-7
 nucleolus 12 1.20 × 10-6
 membrane-enclosed lumen 22 1.20 × 10-6
 nucleoplasm 10 6.60 × 10-3
 intracellular non-membrane-bounded organelle 16 1.20 × 10-1
 non-membrane-bounded organelle 16 1.20 × 10-1
Enrichment cluster 3: Score 2.75 Count P Value
 ribonucleoprotein complex biogenesis 8 1.40 × 10-5
 ribosome biogenesis 7 4.70 × 10-5
 rRNA processing 5 8.90 × 10-4
 rRNA metabolic process 5 9.40 × 10-4
 RNA processing 9 3.80 × 10-3
 ribonucleoprotein complex 9 4.50 × 10-3
 ncRNA processing 5 1.30 × 10-2
 ncRNA metabolic process 5 3.00 × 10-2
Enrichment cluster 4: Score 2.72 Count P Value
 RNA binding 16 6.90 × 10-6
 RNA recognition motif, RNP-1 7 7.10 × 10-4
 Nucleotide-binding, alpha-beta plait 7 1.10 × 10-3
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Enrichment cluster 1: Score 7.09 Count P Value
 mRNA metabolic process 6 3.10 × 10-2
 mrna splicing 4 8.40 × 10-2
 RNA splicing 4 1.10 ×10-1
 mrna processing 4 1.40 × 10-1
 mRNA processing 4 2.00 × 10-1
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Table 2
Predicted transcription factors for the genes less induced in 6 h activated Scapfl/fl versus WT CD8+ T cells.
Transcription Factor P value FDR
CREBBP 2.47 × 10-9 4.55 × 10-3
SREBF2 2.48 × 10-9 6.82 × 10-3
SREBF1 2.65 × 10-8 9.09 × 10-3
NFYA 3.86 × 10-5 1.14 × 10-2
YY1 6.69 × 10-4 1.36 × 10-2
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